HTGM News

AutoGenomics, which sells a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its plans for an initial public offering on Monday. It had first filed to go public in 2008 but withdrew its plans in 2011. It then set terms in February 2013 but withdrew the offering later that year. In February 2015, AutoGenomics planned to raise $45 million at a...read more

14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ composite hit a 1-month low. This week's deals did include the year's largest IPO so far and the first restaurant chain...read more

HTG Molecular Diagnostics, which markets a diagnostic platform for complex molecular profiling, raised $50 million by offering 3.6 million shares at $14, the midpoint of its $13 to $15 range. It priced and began trading on Wednesday. The week's other diagnostics IPO, OpGen (OPGN), priced and began trading on Tuesday. The company slashed its valuation by pricing 33% below...read more

This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, last week's mediocre returns suggest that ...read more